NEW YORK, Oct. 28, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Dementia Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0681717/Dementia-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy
Dementia Global Clinical Trials Review, H2, 2013
Summary
GlobalData's clinical trial report, "Dementia Global Clinical Trials Review, H2, 2013" provides data on the Dementia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Dementia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Dementia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Dementia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by BRIC Nations 15
Clinical Trials by G7 Nations 16
Clinical Trials in G7 Nations by Trial Status 17
Clinical Trials by E7 Nations 18
Clinical Trials in E7 Nations by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Dementia 23
Subjects Recruited Over a Period of Time 26
Prominent Sponsors 27
Top Companies Participating in Dementia Therapeutics Clinical Trials 29
Prominent Drug Comparison 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Johnson & Johnson 32
Clinical Trial Overview of Johnson & Johnson 32
Eisai Co., Ltd. 35
Clinical Trial Overview of Eisai Co., Ltd. 35
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
H. Lundbeck A/S 40
Clinical Trial Overview of H. Lundbeck A/S 40
Teva Pharmaceutical Industries Limited 41
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 41
Forest Laboratories, Inc. 42
Clinical Trial Overview of Forest Laboratories, Inc. 42
Eli Lilly and Company 43
Clinical Trial Overview of Eli Lilly and Company 43
Merck & Co., Inc. 44
Clinical Trial Overview of Merck & Co., Inc. 44
Bristol-Myers Squibb Company 45
Clinical Trial Overview of Bristol-Myers Squibb Company 45
Clinical Trial Overview of Top Institutes / Government 46
U.S. Department of Veterans Affairs 46
Clinical Trial Overview of U.S. Department of Veterans Affairs 46
VU University Medical Center 47
Clinical Trial Overview of VU University Medical Center 47
National Institute of Mental Health 48
Clinical Trial Overview of National Institute of Mental Health 48
National Institute of Neurological Disorders and Stroke 49
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 49
Sykehuset Innlandet HF 50
Clinical Trial Overview of Sykehuset Innlandet HF 50
National Institute on Aging 51
Clinical Trial Overview of National Institute on Aging 51
Radboud University 52
Clinical Trial Overview of Radboud University 52
University of California, San Francisco 53
Clinical Trial Overview of University of California, San Francisco 53
Penn State University 54
Clinical Trial Overview of Penn State University 54
Samsung Medical Center 55
Clinical Trial Overview of Samsung Medical Center 55
Five Key Clinical Profiles 56
Appendix 111
Abbreviations 111
Definitions 111
Research Methodology 112
Secondary Research 112
About GlobalData 113
Contact Us 113
Disclaimer 113
Source 114
List of Tables
Dementia Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Dementia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Dementia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Dementia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 10
Dementia Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Dementia Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Dementia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
Dementia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 14
Dementia Therapeutics Clinical Trials, BRIC Countries, 2013* 15
Dementia Therapeutics Clinical Trials, G7 Countries, 2013* 16
Dementia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Dementia Therapeutics Clinical Trials, E7 Countries, 2013* 18
Dementia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Dementia Therapeutics Market, Global, Clinical Trials by Phase, 2013* 20
Dementia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 21
Dementia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Dementia Therapeutics Market, Global, Suspended Clinical Trials, 2013* 23
Dementia Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 23
Dementia Therapeutics Market, Global, Terminated Clinical Trials, 2013* 24
Dementia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 26
Dementia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
Dementia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
Dementia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 31
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2013* 32
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Co., Ltd., 2013* 35
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 37
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 39
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2013* 40
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013* 41
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2013* 42
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 43
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 44
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2013* 45
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 46
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2013* 47
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2013* 48
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2013* 49
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sykehuset Innlandet HF, 2013* 50
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute on Aging, 2013* 51
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2013* 52
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2013* 53
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Penn State University, 2013* 54
Dementia Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2013* 55
List of Figures
Dementia Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Dementia Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Dementia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Dementia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 10
Dementia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Dementia Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Dementia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 13
Dementia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 14
Dementia Therapeutics Clinical Trials, BRIC Countries (%), 2013* 15
Dementia Therapeutics Clinical Trials, G7 Countries (%), 2013* 16
Dementia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 17
Dementia Therapeutics Clinical Trials, E7 Countries (%), 2013* 18
Dementia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 19
Dementia Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 20
Dementia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 21
Dementia Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 22
Dementia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 26
Dementia Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 27
Dementia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 29
Dementia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 31
GlobalData Methodology 112
To order this report: Dementia Global Clinical Trials Review, H2, 2013
http://www.reportlinker.com/p0681717/Dementia-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Therapy
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article